Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner

According to the literature, the autoantigen La is involved in Cap-independent translation. It was proposed that one prerequisite for this function is the formation of a protein dimer. However, structural analyses argue against La protein dimers. Noteworthy to mention, these structural analyses were...

Full description

Bibliographic Details
Main Authors: Nicole Berndt, Claudia C. Bippes, Irene Michalk, Dominik Bachmann, Jennifer Bachmann, Edinson Puentes-Cala, Tabea Bartsch, Liliana R. Loureiro, Alexandra Kegler, Ralf Bergmann, Joanne K. Gross, Tim Gross, Biji T. Kurien, R. Hal Scofield, A. Darise Farris, Judith A. James, Marc Schmitz, Karim Fahmy, Anja Feldmann, Claudia Arndt, Michael P. Bachmann
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/7/3377
_version_ 1797540033825079296
author Nicole Berndt
Claudia C. Bippes
Irene Michalk
Dominik Bachmann
Jennifer Bachmann
Edinson Puentes-Cala
Tabea Bartsch
Liliana R. Loureiro
Alexandra Kegler
Ralf Bergmann
Joanne K. Gross
Tim Gross
Biji T. Kurien
R. Hal Scofield
A. Darise Farris
Judith A. James
Marc Schmitz
Karim Fahmy
Anja Feldmann
Claudia Arndt
Michael P. Bachmann
author_facet Nicole Berndt
Claudia C. Bippes
Irene Michalk
Dominik Bachmann
Jennifer Bachmann
Edinson Puentes-Cala
Tabea Bartsch
Liliana R. Loureiro
Alexandra Kegler
Ralf Bergmann
Joanne K. Gross
Tim Gross
Biji T. Kurien
R. Hal Scofield
A. Darise Farris
Judith A. James
Marc Schmitz
Karim Fahmy
Anja Feldmann
Claudia Arndt
Michael P. Bachmann
author_sort Nicole Berndt
collection DOAJ
description According to the literature, the autoantigen La is involved in Cap-independent translation. It was proposed that one prerequisite for this function is the formation of a protein dimer. However, structural analyses argue against La protein dimers. Noteworthy to mention, these structural analyses were performed under reducing conditions. Here we describe that La protein can undergo redox-dependent structural changes. The oxidized form of La protein can form dimers, oligomers and even polymers stabilized by disulfide bridges. The primary sequence of La protein contains three cysteine residues. Only after mutation of all three cysteine residues to alanine La protein becomes insensitive to oxidation, indicating that all three cysteines are involved in redox-dependent structural changes. Biophysical analyses of the secondary structure of La protein support the redox-dependent conformational changes. Moreover, we identified monoclonal anti-La antibodies (anti-La mAbs) that react with either the reduced or oxidized form of La protein. Differential reactivities to the reduced and oxidized form of La protein were also found in anti-La sera of autoimmune patients.
first_indexed 2024-03-10T12:54:19Z
format Article
id doaj.art-84b383b0c42a4df9ac0795ed5eaa295b
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T12:54:19Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-84b383b0c42a4df9ac0795ed5eaa295b2023-11-21T12:01:20ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01227337710.3390/ijms22073377Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent MannerNicole Berndt0Claudia C. Bippes1Irene Michalk2Dominik Bachmann3Jennifer Bachmann4Edinson Puentes-Cala5Tabea Bartsch6Liliana R. Loureiro7Alexandra Kegler8Ralf Bergmann9Joanne K. Gross10Tim Gross11Biji T. Kurien12R. Hal Scofield13A. Darise Farris14Judith A. James15Marc Schmitz16Karim Fahmy17Anja Feldmann18Claudia Arndt19Michael P. Bachmann20Department of Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, GermanyInstitute of Immunology, Medical Faculty Carl Gustav Carus Dresden, Technical University Dresden, 01307 Dresden, GermanyInstitute of Immunology, Medical Faculty Carl Gustav Carus Dresden, Technical University Dresden, 01307 Dresden, GermanyUniversity Cancer Center (UCC), Tumor Immunology, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, 01307 Dresden, GermanyUniversity Cancer Center (UCC), Tumor Immunology, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, 01307 Dresden, GermanyDepartment of Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, GermanyDepartment of Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, GermanyDepartment of Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, GermanyDepartment of Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, GermanyDepartment of Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, GermanyThe Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USAThe Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USAThe Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USAThe Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USAThe Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USAThe Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USAInstitute of Immunology, Medical Faculty Carl Gustav Carus Dresden, Technical University Dresden, 01307 Dresden, GermanyInstitute of Resource Ecology, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, GermanyDepartment of Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, GermanyDepartment of Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, GermanyDepartment of Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, GermanyAccording to the literature, the autoantigen La is involved in Cap-independent translation. It was proposed that one prerequisite for this function is the formation of a protein dimer. However, structural analyses argue against La protein dimers. Noteworthy to mention, these structural analyses were performed under reducing conditions. Here we describe that La protein can undergo redox-dependent structural changes. The oxidized form of La protein can form dimers, oligomers and even polymers stabilized by disulfide bridges. The primary sequence of La protein contains three cysteine residues. Only after mutation of all three cysteine residues to alanine La protein becomes insensitive to oxidation, indicating that all three cysteines are involved in redox-dependent structural changes. Biophysical analyses of the secondary structure of La protein support the redox-dependent conformational changes. Moreover, we identified monoclonal anti-La antibodies (anti-La mAbs) that react with either the reduced or oxidized form of La protein. Differential reactivities to the reduced and oxidized form of La protein were also found in anti-La sera of autoimmune patients.https://www.mdpi.com/1422-0067/22/7/3377anti-La/SS-B antibodiesautoimmunityLa/SS-B autoantigensystemic lupus erythematosusprimary Sjögren’s syndrome
spellingShingle Nicole Berndt
Claudia C. Bippes
Irene Michalk
Dominik Bachmann
Jennifer Bachmann
Edinson Puentes-Cala
Tabea Bartsch
Liliana R. Loureiro
Alexandra Kegler
Ralf Bergmann
Joanne K. Gross
Tim Gross
Biji T. Kurien
R. Hal Scofield
A. Darise Farris
Judith A. James
Marc Schmitz
Karim Fahmy
Anja Feldmann
Claudia Arndt
Michael P. Bachmann
Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner
International Journal of Molecular Sciences
anti-La/SS-B antibodies
autoimmunity
La/SS-B autoantigen
systemic lupus erythematosus
primary Sjögren’s syndrome
title Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner
title_full Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner
title_fullStr Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner
title_full_unstemmed Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner
title_short Two Be or Not Two Be: The Nuclear Autoantigen La/SS-B Is Able to Form Dimers and Oligomers in a Redox Dependent Manner
title_sort two be or not two be the nuclear autoantigen la ss b is able to form dimers and oligomers in a redox dependent manner
topic anti-La/SS-B antibodies
autoimmunity
La/SS-B autoantigen
systemic lupus erythematosus
primary Sjögren’s syndrome
url https://www.mdpi.com/1422-0067/22/7/3377
work_keys_str_mv AT nicoleberndt twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT claudiacbippes twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT irenemichalk twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT dominikbachmann twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT jenniferbachmann twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT edinsonpuentescala twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT tabeabartsch twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT lilianarloureiro twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT alexandrakegler twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT ralfbergmann twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT joannekgross twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT timgross twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT bijitkurien twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT rhalscofield twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT adarisefarris twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT judithajames twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT marcschmitz twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT karimfahmy twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT anjafeldmann twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT claudiaarndt twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner
AT michaelpbachmann twobeornottwobethenuclearautoantigenlassbisabletoformdimersandoligomersinaredoxdependentmanner